DK143562B - PROCEDURE FOR THE PREPARATION OF (-) - VINCAMIN - Google Patents

PROCEDURE FOR THE PREPARATION OF (-) - VINCAMIN Download PDF

Info

Publication number
DK143562B
DK143562B DK16772A DK16772A DK143562B DK 143562 B DK143562 B DK 143562B DK 16772 A DK16772 A DK 16772A DK 16772 A DK16772 A DK 16772A DK 143562 B DK143562 B DK 143562B
Authority
DK
Denmark
Prior art keywords
vincamine
formula
oxide
vincadifformin
equimolar amount
Prior art date
Application number
DK16772A
Other languages
Danish (da)
Other versions
DK143562C (en
Inventor
J Levy
Original Assignee
Omnium Chimique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE761628A external-priority patent/BE761628A/en
Priority claimed from BE763730A external-priority patent/BE763730R/en
Application filed by Omnium Chimique Sa filed Critical Omnium Chimique Sa
Publication of DK143562B publication Critical patent/DK143562B/en
Application granted granted Critical
Publication of DK143562C publication Critical patent/DK143562C/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Description

143562143562

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af (-)-vincamin med formlen;The present invention relates to a particular process for the preparation of (-) - vincamine of the formula;

CoO» f | (V) H0-\/\/CoO »f | (V) H0 - \ / \ /

/ I/ I

/ ! h3cooc' \/! h3cooc '\

VV

Den fremstillede (-)-vincamin udgør et mellemprodukt ved syntesen af såvel naturlig vincamin og epi-16-vincamin som apo-vinca-min.The (-) - vincamine produced is an intermediate in the synthesis of both natural vincamine and epi-16 vincamine as well as apo-vinca min.

Det er kendt, at vincamin og epl-vincamin er alcaloider, der kan isoleres fra Vinca minor. Ved dehydrering i surt miljø giver disse to produkter samme derivat, apo-vincamin.It is known that vincamine and apple vincamine are alkaloids which can be isolated from Vinca minor. When dehydrated in an acidic environment, these two products give the same derivative, apo-vincamine.

Vincamin og dets derivater frembyder interessante farmakologiske egenskaber ved terapeutisk anvendelse. Imidlertid er deres anvendelse begrænset som følge af, at Vinca minor kun indeholder lidt vincamin og meget lidt epi-16-vincamin, og at disse to alcaloider såvel som apo-vincamin og andre produkter, der afledes heraf, er kostbare stoffer.Vincamine and its derivatives present interesting pharmacological properties of therapeutic use. However, their use is limited due to the fact that Vinca minor contains only a little vincamine and very little epi-16-vincamine, and that these two alkaloids as well as apo-vincamine and other derived products are expensive substances.

Der kendes flere fremgangsmåder til syntese af vincamin og derivater heraf, men disse kendte fremgangsmåder giver kun ringe udbytte og fører til racemiske produkter.Several methods are known for the synthesis of vincamine and its derivatives, but these known methods give only poor yield and lead to racemic products.

Formålet med den foreliggende opfindelse er at tilvejebringe en enkel og selektiv fremgangsmåde til fremstilling af (-)-vincamin i stort udbytte.The object of the present invention is to provide a simple and selective process for producing (-) - vincamine in high yield.

Dette formål opnås ifølge opfindelsen med en fremgangsmåde, der er ejendommelig ved, at (-)-tabersonin med formlen: CøThis object is achieved according to the invention by a method characterized in that (-) - tabersonin of the formula: C0

OcOn i T ! C00CH3 j 2 143562 i et første trin hydrogeneres katalytisk til næsten kvantitativ opnåelse af (-)-vincadifformin med formlen: rVir-' ^Vr i H C00CH3 ' og at det således opnåede (-)-vincadifformin (a) enten behandles med en ækvimolær mængde af et peroxid for i et andet trin at omdanne denne forbindelse til (-)-vincadifformin-N-oxid med formlen: 0OcOn i T! C00CH3 in a first step is catalytically hydrogenated to give almost quantitative yield of (-) - vincadifformin of the formula: rVir- 'Vr in H C00CH3' amount of a peroxide to convert in this second step to (-) - vincadifformin N-oxide of the formula: 0

HriV'-HriV'-

HH

cooch3 ; og at det således opnåede (-)-vincadifformin-N-oxid i et tredie trin påny behandles med en ækvimolær mængde af et peroxid til opnåelse af (-)-1 f2-dehydro-16-carbomethoxy-16-hydroxy-aspidospermidin-N--oxid med formlen: 0 nrW- uv) C00CH3 eller (b) behandles med to mol peroxid pr. mol (-)-vincadifformin i 143562 3 længere tid til direkte dannelse af (-)-1,2-dehydro-16-carbomethoxy--16-hydroxy-aspido-sperm?din-N-oxid med formlen IV, og at forbindelsen med formlen IV behandles med en ækvimolær mængde af triphenyl-phosphin eller med et andet reduktionsmiddel for N-oxidgruppen i surt miljø til omlejring af produktet til en blanding af (-)-vincamin, 16-epi-vincamin og apo-vincamin, hvorefter (-)-vincamin udvindes.cooch3; and that the (-) - vincadifformin-N-oxide thus obtained is again treated in a third step with an equimolar amount of a peroxide to give (-) - 1β-dehydro-16-carbomethoxy-16-hydroxy-aspidospermidine-N - oxide of the formula: 0 noW-uv) C00CH3 or (b) treated with two moles of peroxide per mole (-) - vincadifformin for a longer time to directly form (-) - 1,2-dehydro-16-carbomethoxy - 16-hydroxy-aspido-spermidine-N-oxide of formula IV, and the compound of formula IV is treated with an equimolar amount of triphenylphosphine or with another reducing agent for the N-oxide group in an acidic environment to rearrange the product into a mixture of (-) - vincamine, 16-epi-vincamine and apo-vincamine, then ( -) - vincamine is extracted.

I dansk patentansøgning nr. 1531/71 er der beskrevet en fremgangsmåde til fremstilling af (-)-vincamin ud fra cis-1,2,3,4,6,7, 12,12b-octahydro-1β-ethyl-1of-carbomethoxyβthyl-12bβ-indolo-(2,3-a) quinazolin. Denne forbindelse omdannes til en lactamforbindelse, 14--oxo^,^(20)-E-homo-eburnan, der over den tilsvarende hydroxy-iminoforbindelse, 14-oxo-15-hydroxyimino-35,^(20)-E-homo-eburnan og dioxoforbindelse, 14,15-Ρΐοχο-3β,16β(20)“Ε-|·ιοτηο-βηυΓη3η omdannes til (-)-vincamin.Danish Patent Application No. 1531/71 discloses a process for the preparation of (-) - vincamine from cis-1,2,3,4,6,7, 12,12b-octahydro-1β-ethyl-1of-carbomethoxyβthyl -12bβ-indolo- (2,3-a) quinazoline. This compound is converted to a lactam compound, 14-oxo-, (20) -E-homo-eburnan, which over the corresponding hydroxy-imino compound, 14-oxo-15-hydroxyimino-35, (20) -E-homo -eburnan and dioxo compound, 14,15-Ρΐοχο-3β, 16β (20) “Ε- | · ιοτηο-βηυΓη3η is converted to (-) - vincamine.

Ved den praktiske gennemførelse af fremgangsmåden ifølge opfindelsen kan det som udgangsmateriale, anvendte tabersonin være opnået ud fra Voacanga-korn, hvor dette alcaloid findes disponibelt i forholdsvis store mængder. Fremstillingen af tabersonin gennemføres hensigtsmæssigt ved hjælp af den fremgangsmåde, der er omtalt i fransk patentansøgning nr. 69 09 002.In the practical implementation of the process according to the invention, the tabersonin used as a starting material may be obtained from Voacanga grains, where this alkaloid is available in relatively large quantities. The preparation of tabersonin is conveniently carried out by the method disclosed in French Patent Application No. 69 09 002.

Omlejringen i sluttrinnet ved fremgangsmåden ifølge opfindelsen fører som nævnt til en blanding af (-)-vincamin (V), epi-16--vincamin (VI) og apo-vincamin (VII), der har følgende formler: ccci, ooa cc®.As mentioned, the final step rearrangement of the process according to the invention results in a mixture of (-) - vincamine (V), epi-16 - vincamine (VI) and apo-vincamine (VII) having the following formulas: ccci, ooa cc® .

H0—H3C00C H-COOCH0 — H3C00C H-COOC

, v / ! 3 I, v /! 3 I

/ ; / j I/; / j I

HjCOOC7 H0 (V) (VI) (VII)HjCOOC7 H0 (V) (VI) (VII)

Ved hjælp af chromatografi kan den således opnåede blanding skilles i to fraktioner. Den mest polære fraktion består af en hovedmængde vincamin og en mindre mængde epi-vincamin, der kan adskilles ved hjælp af krystallisation. Den mindst polære fraktion giver ved krystallisaton apo-vincamin.By means of chromatography, the mixture thus obtained can be separated into two fractions. The most polar fraction consists of a major amount of vincamine and a smaller amount of epi-vincamine which can be separated by crystallization. The least polar fraction gives crystallisaton apo-vincamine.

143562 4143562 4

Fraktioneringen af forbindelserne V, VI og VII kan gennemføres ved hjælp af flere på hinanden følgende krystallisationer uden at gøre brug af chromatografi.The fractionation of compounds V, VI and VII can be carried out by several successive crystallizations without using chromatography.

Nærmere bestemt gennemføres de forskellige trin ved fremgangsmåden ifølge den foreliggende opfindelse hensigtsmæssigt på følgende måde: I det første trin hydrogeneres (-)-tabersonin, der er opløst i en alkohol ved almindeligt tryk i nærværelse af en katalysator såsom PtOg eller Pd/C til optagelse af det teoretiske rumfang. Katalysatoren adskilles fra opløsningen ved filtrering på diatoméjord. Opløsningen inddampes i vakuum. Resten om krystalliseres i en methanol-etherblan-ding. Smeltepunkt 96°C (a)D = -600° (ethanol).Specifically, the various steps of the process of the present invention are conveniently carried out as follows: In the first step, (-) - tabersonin, which is dissolved in an alcohol at ordinary pressure, is hydrogenated in the presence of a catalyst such as PtOg or Pd / C for uptake of theoretical volume. The catalyst is separated from the solution by filtration on diatomaceous earth. The solution is evaporated in vacuo. The residue is crystallized in a methanol-ether mixture. Melting point 96 ° C (a) D = -600 ° (ethanol).

I det andet trin behandles (-)-vincadifformin i 1-5 timer med en ækvimolær mængde af en persyre ved almindelig temperatur i en nitrogenatmosfære uden lysets adgang i et opløsningsmiddel, der er ikke-blandbart med vand og af aromatisk type, såsom benzen eller toluen, af etheroxidtypen eller af en type, der består af et chloreret, alifatisk carbonhydrid, der er afledt af methan eller ethan, såsom methylenchlorid, carbontetrachlorid, chloroform eller trichlorethylen eller tetrachlorethan.In the second step, (-) - vincadifformin is treated for 1-5 hours with an equimolar amount of a peracid at ordinary temperature in a nitrogen atmosphere without the light's access in a water-immiscible and aromatic solvent such as benzene or toluene, of the ether oxide type or of a type consisting of a chlorinated aliphatic hydrocarbon derived from methane or ethane such as methylene chloride, carbon tetrachloride, chloroform or trichloroethylene or tetrachloroethane.

Reaktionsopløsningen vaskes med en vandig alkalisk opløsning for at fjerne hovedmængden af peroxideringsmidlet og dets omdannelsesprodukter, hvorefter der destilleres indtil opnåelse af en rest, der udgøres af (-)-vincadifformin-N-oxid (III) og foreligger i et udbytte på omkring 90%. Dette kan som sådant omdannes til (IV), eller det kan først renses ved hjælp af krystallisation i en blanding af flygtige opløsningsmidler.The reaction solution is washed with an aqueous alkaline solution to remove the bulk of the peroxidizing agent and its conversion products, then distilled to give a residue consisting of (-) - vincadifformin N-oxide (III) and present in a yield of about 90% . As such, this can be converted to (IV) or it can first be purified by crystallization in a mixture of volatile solvents.

Smeltepunkt: 160°C (dekomponering) (a)D = -213 (C = 1 methanol) U.V. (methanol max. ved λ log ε : 228 (3,99), 297 (3,99) og 331 (4,11) nm “1 I.R. bind konjugeret ester ved 1670 og 1610 cmMelting point: 160 ° C (decomposition) (a) D = -213 (C = 1 methanol) U.V. (methanol max. at λ log ε: 228 (3.99), 297 (3.99) and 331 (4.11) nm

Massespektrum molekylspids N+ ved m/e 354Mass spectrum molecular peak N + at m / e 354

Analyse C21H26°3N2 beregnet % C 71,17 H 7,39 fundet % C 70,9 H 7,3 I det tredie trin behandles (-)-vincadifformin-N-oxid (III) 143562 5 med en ækvimolær mængde af en persyre som i det tidligere trin men i 1-5 dage til opnåelse i et udbytte omkring 80% af (-)-l,2-dihydro- 16-carbomethoxy-16-hydroxy-aspidospermidin-N-oxid (IV), der kan renses ved hjælp af krystallisation i et flygtigt opløsningsmiddel eller anvendes som sådant i det fjerde trin ved fremgangsmåden.Analysis C21H26 ° 3N2 calculated% C 71.17 H 7.39 found% C 70.9 H 7.3 In the third step, (-) - vincadifformin N-oxide (III) is treated with an equimolar amount of a peracid as in the previous step but for 1-5 days to obtain in a yield about 80% of (-) - 1,2-dihydro-16-carbomethoxy-16-hydroxy-aspidospermidine N-oxide (IV) which can be purified by crystallization in a volatile solvent or as such is used in the fourth step of the process.

Smeltepunkt: 178-180°C (dekomponering) (ot)p = 107° (C = 1 methanol) U.V. (methanol) max. ved λ log ε : 223 (4,29), 270 (3,73) nm »1 I.R. carbonylester ikke-konjugeret 1738 cm Massespektrum molekylspids M+ ved m/e 370 Analyse C21H26°4N2 beregnet % C 68,09 H 7,07 fundet % C 67,9 H 7,0Melting point: 178-180 ° C (decomposition) (ot) p = 107 ° (C = 1 methanol) U.V. (methanol) max. at λ log ε: 223 (4.29), 270 (3.73) nm »1 I.R. carbonyl ester non-conjugated 1738 cm Mass spectrum molecular peak M + at m / e 370 Analysis C21H26 ° 4N2 Calcd% C 68.09 H 7.07 Found% C 67.9 H 7.0

De persyrer, der anvendes i det andet og tredie trin, kan være ens eller forskellige. De kan være følgende: Pereddikesyre, perbenzosyre, metachlorperbenzosyre, paranitroperbenzosyre, trifluor-pereddikesyre, permyresyre, perphthalsyre.The peracids used in the second and third steps may be the same or different. They can be the following: Peracetic acid, perbenzoic acid, metachloroperbenzoic acid, paranitroperbenzoic acid, trifluoro-peracetic acid, permyric acid, perphthalic acid.

Det er som nævnt ikke nødvendigt at isolere mellemproduktet (III), men (-)-vincadifformin (II) kan behandles med en dobbelt ækvimolær mængde persyre ved de ovenfor definerede betingelser i 1-5 dage. Der opnås derved et udbytte omkring 85%.As mentioned, it is not necessary to isolate the intermediate (III), but (-) - vincadifformin (II) can be treated with a double equimolar amount of peracid under the conditions defined above for 1-5 days. A yield of about 85% is thus obtained.

En foretrukket udførelsesform for fremgangsmåden ifølge opfindelsen er ejendommelig ved, at forbindelsen med formlen IV og en ækvimolær mængde triphenylphosphin opløses i en væskeformig organisk syre med lav molekylvægt og fortrinsvis i eddikesyre, at opløsningen efter to timers kogning i nitrogenatmosfære afkøles, fortyndes med en lige så stor mængde vand og vaskes med en dobbelt så stor mængde benzen eller ether for at fjerne det dannede triphenyl-phosphinoxid, at den flygtige organiske fase fjernes ved dekantering, at den sure vandige fase derefter gøres alkalisk til en pH-værdi på 10 og ekstraheres med et organisk opløsningsmiddel, at den organiske fase fradekanteres, vaskes med rent vand og tørres over et vandabsorptionsmiddel, og at opløsningsmidlet til slut fjernes ved destillation.A preferred embodiment of the process according to the invention is characterized in that the compound of formula IV and an equimolar amount of triphenylphosphine are dissolved in a low molecular weight liquid organic acid and preferably in acetic acid, so that the solution is cooled, after two hours, in an atmosphere of nitrogen. large amount of water and washed with twice the amount of benzene or ether to remove the resulting triphenylphosphine oxide that the volatile organic phase is removed by decantation, then the acidic aqueous phase is then made alkaline to a pH of 10 and extracted with an organic solvent, the organic phase is decanted off, washed with pure water and dried over a water absorbent, and finally the solvent is removed by distillation.

Denne udførelsesform frembyder den fordel, at de anvendte reagenser triphenylphosphin og eddikesyre er lette at anvende og er lettilgængelige forbindelser, samt at der opnås et godt udbytte, nemlig ca. 85%.This embodiment offers the advantage that the reagents used are triphenylphosphine and acetic acid are easy to use and are readily available compounds, and that a good yield is obtained, namely approx. 85%.

143562 6143562 6

For at isolere (-)-vincamin (V), epi-16-vincamin (VI) og apo-vincamin opløses den ubehandlede rest fra den forudgående reaktion i 10 dele benzen og chromatograferes pi en kolonne med 30 dele aluminiumoxid. Elueringen gennemføres successivt med benzen, en blanding af benzen og ether (80-20) og ren ether. Ved krystallisation i acetone giver hver af disse fraktioner henholdsvis apo-vincamin (VII), vincamin (V) og epi-16-vincamin (VI) i respektive mængder omkring 25%, 50% og 25%.To isolate (-) - vincamine (V), epi-16-vincamine (VI) and apo-vincamine, the crude residue from the previous reaction is dissolved in 10 parts of benzene and chromatographed on a column of 30 parts of alumina. The elution is carried out successively with benzene, a mixture of benzene and ether (80-20) and pure ether. Upon crystallization in acetone, each of these fractions gives apo-vincamine (VII), vincamine (V) and epi-16-vincamine (VI), respectively, in about amounts of about 25%, 50% and 25%.

Behandlingen af forbindelsen med formlen IV med triphenyl-phosphin gennemføres fortrinsvis ved stuetemperatur i løbet af ca. 12 timer i vandigt eddikesyremiljø. Det ubehandlede produkt, der herved opnås, opnås i et udbytte på omkring 85% og indeholder meget lidt apo-vincamin (VII), og vincamin (V) og epi-16-vincamin (VI) i et forhold på 3:1. Af denne blanding kan vincaminet isoleres ved to krystallisationer i acetone, methanol, ethanol eller propanol.The treatment of the compound of formula IV with triphenylphosphine is preferably carried out at room temperature over about 30 minutes. 12 hours in aqueous acetic acid environment. The untreated product thus obtained is obtained in a yield of about 85% and contains very little apo-vincamine (VII), and vincamine (V) and epi-16-vincamine (VI) in a ratio of 3: 1. From this mixture, the vincamine can be isolated by two crystallizations in acetone, methanol, ethanol or propanol.

De følgende eksempler belyser de karakteristiske træk ved fremgangsmåden ifølge den foreliggende opfindelse.The following examples illustrate the characteristic features of the method of the present invention.

EKSEMPEL 1 a) Fremstilling af (-)-vincadifformin (II) ud fra (I)EXAMPLE 1 a) Preparation of (-) - vincadifformin (II) from (I)

En konstant omrørt opslemning af 200 g Adams platinoxid i 10 liter methanol mættes med hydrogen i en time ved almindelig temperatur og tryk, hvorefter der hurtigt tilsættes en opløsning af 1 kg tabersonin i 10 liter methanol, og omrøringen fortsættes. Den teoretiske mængde hydrogen optages i løbet af 6 timer. Katalysatoren fjernes derefter ved filtrering på kiselgur, og filtratet destilleres indtil tørhed, hvorved der fås 985 g hydrogeneret derivat (II) i form af en gennemsigtig lak, der ved omkrystallisation i en methanol-etherblan-ding giver (-)-vincadifformin. Smeltepunkt 96°C, (oOq = -600° (ethanol).A constantly stirred slurry of 200 g of Adams platinum oxide in 10 liters of methanol is saturated with hydrogen for one hour at room temperature and pressure, then a solution of 1 kg of tabersonin in 10 liters of methanol is rapidly added and stirring is continued. The theoretical amount of hydrogen is absorbed within 6 hours. The catalyst is then removed by filtration on diatomaceous earth and the filtrate distilled to dryness to give 985 g of hydrogenated derivative (II) in the form of a transparent lacquer which, by recrystallization in a methanol-ether mixture, gives (-) - vincadifformin. Melting point 96 ° C (o 0 = -600 ° (ethanol)).

b) Fremstilling af (-)-vincadifformin-N-oxid (III) ud fra (-)-vincadif-formin (II)b) Preparation of (-) - vincadifformin N-oxide (III) from (-) - vincadifformin (II)

En opløsning af 1,3 kg (-)-vincadifformin og 800 g parani-troperbenzosyre i 200 liter tørt benzen henstilles i en nitrogenatmosfære og i fravær af lys. Efter 4 timers forløb ved disse betingelser gennemføres der en kontrol ved hjælp af chromatografi på plade med 143562 7 et tyndt lag silicagel (elueringsmiddel: benzen 50, methanol 39, ether 10 og ammoniak 1) til en prøve, der viser den fuldstændige forsvinden af den oprindelige blå plet, der er tilvejebragt af (-)-vincadfffor-minet med det reagerende middel på basis af ammoniakalsk ceriumsulfat og dens erstatning med en anden blå plet med klart mindre Rf. Benzenopløsningen vaskes derefter med en natrfumhydrogencarbonat-opløsning og med vand. Efter tørring af benzenopløsningen og af-destillation af opløsningsmidlet opnås en tyk olie, der vejer 1,380 kg (udbytte 90%), der ved omkrystallisation i en methylenchlorid-ether-blanding giver (-)-vincadifformin-N-oxid (III). Smeltepunkt 160°C.A solution of 1.3 kg of (-) - vincadifformin and 800 g of paranitroperbenzoic acid in 200 liters of dry benzene is recommended in a nitrogen atmosphere and in the absence of light. After 4 hours under these conditions, a thin layer of silica gel (eluent: benzene 50, methanol 39, ether 10 and ammonia 1) was checked by plate chromatography for a sample showing the complete disappearance of the original blue stain provided by the (-) - vincadff formulated with the ammoniacal cerium sulfate reactant and its replacement with another blue stain with clearly less Rf. The benzene solution is then washed with a sodium hydrogen carbonate solution and with water. After drying the benzene solution and distilling off the solvent, a thick oil weighing 1,380 kg (90% yield) is obtained which, by recrystallization in a methylene chloride-ether mixture, gives (-) - vincadifformin-N-oxide (III). Melting point 160 ° C.

c) Fremstilling af (-) 1,2-dehydro-16-carboroethoxy-16 hydroxy-aspido-spermidin-N-oxid (IV) ud fra (III)c) Preparation of (-) 1,2-dehydro-16-carboroethoxy-16 hydroxy-aspido-spermidine N-oxide (IV) from (III)

En opløsning af 1,410 kg (-)-vincadifformin-N-oxid (111) og 800 g paranitroperbenzosyre i 200 liter tør benzen henstår i nitrogenatmosfære og i fravær af lys. Efter 4 dages forløb ved disse betingelser gennemføres en kontrol ved hjælp af chromatografi på tyndtlags-plade til en prøve, der viser fuldstændig forsvinden af den oprindelige blå plet, der fis af (-)-vincadifformin-N-oxid med reagenset på grundlag af ammoniakalsk ceriumsulfat og dens erstatning med et produkt, der ikke fremkaldes med nævnte reagens, men som giver en brun plet med Dragendorff-reagenset.A solution of 1,410 kg (-) - vincadifformin N-oxide (111) and 800 g of paranitroperbenzoic acid in 200 liters of dry benzene is left in a nitrogen atmosphere and in the absence of light. After 4 days under these conditions, a thin-layer chromatography check was performed for a sample showing complete disappearance of the original blue spot showing (-) - vincadifformin N-oxide with the ammonia-based reagent cerium sulphate and its replacement with a product which is not developed with said reagent but which gives a brown stain with the Dragendorff reagent.

Reaktionsopløsningen behandles derefter som i det foregående forsøg. Man opnår til slut en tyk olie, der vejer 1,320 kg (udbytte 89%), der ved om krystallisation i en methylenchlorid-etherblanding giver produktet (IV) på krystalliseret form. Smeltepunkt 178-180°C under nedbrydning.The reaction solution is then treated as in the previous experiment. Finally, a thick oil weighing 1,320 kg (yield 89%) is obtained, which knows about crystallization in a methylene chloride-ether mixture gives the product (IV) in crystallized form. Melting point 178-180 ° C during decomposition.

d) Fremstilling af (-)-vincamin (V), epi-16-vincamin (VI) og apo-vin-camin (VIII) ud fra (IV) ved omlejringd) Preparation of (-) - vincamine (V), epi-16-vincamine (VI) and apo-vinamine (VIII) from (IV) by rearrangement

En opløsning af 1,110 kg af (VI) og 780 g triphenylphosphin i 100 liter ren eddikesyre opvarmes under tf I bages va ling i 2 timer. Reaktionsopløsningen fortyndes med et lige så stort rumfang isvand og vaskes med 50 liter benzen, der fjerner 120 g triphenylphosphin-oxid. Derefter gøres opløsningen alkalisk ved hjælp af natriumhydro-gencarbonat og ekstraheres to gange med 50 liter methylenchlorid. Methylenchloridopløsningerne giver efter vaskning med vand og tørring ved destillation en olieagtig rest, der vejer 950 g (udbytte 86%).A solution of 1,110 kg of (VI) and 780 g of triphenylphosphine in 100 liters of pure acetic acid is heated under reflux for 2 hours. The reaction solution is diluted with an equal volume of ice water and washed with 50 liters of benzene which removes 120 g of triphenylphosphine oxide. The solution is then made alkaline by means of sodium hydrogen carbonate and extracted twice with 50 liters of methylene chloride. The methylene chloride solutions, after washing with water and drying by distillation, give an oily residue weighing 950 g (yield 86%).

En analyse ved hjælp af chromatografi på tyndtlagsplade viser med U3562 8An analysis by thin layer chromatography shows with U3562 8

Dragendorff-reagenset tilstedeværelsen i denne olieagtige rest af tre bestanddele, der har samme Rf-værdi som apo-vincamin, vincamin og epi-16-vicamin i rækkefølge efter faldende Rf-værdi. Denne olieagtige rest chromatograferes opløst i 10 liter benzen på en søjle af 30 kg aluminiumoxid. Ved successive elueringer med benzen, benzen-20% etherblandinger og ren ether opnås der tre fraktioner, der ved omkrystallisation i acetone giver tre rene produkter, der ved hjælp af deres fysiske konstanter (F, (oO^, U.V., I.R., massespektrum) identificeres med referenceprøver som: apo-vincamin (VII) (120 g), vincamin (V) (330 g) og epi-16-vincamin (VI) (150 g). Den samme reaktion mellem (IV) og triphenylphosphinet gennemført i eddikesyre i de samme forhold men ved stuetemperatur i 12 timer gav et udbytte på 85% af en rå blanding, der kun indeholder spor af apo-vincamin, og som stort set består af vincamin (V) (3 dele) og epi-16-vincamin (VI) (1 del).The Dragendorff reagent is present in this oily residue of three constituents having the same Rf value as apo-vincamine, vincamine and epi-16-vicamine in order of decreasing Rf value. This oily residue is chromatographed dissolved in 10 liters of benzene on a column of 30 kg alumina. By successive elutions with benzene, benzene-20% ether mixtures, and pure ether, three fractions are obtained which, upon recrystallization in acetone, yield three pure products which are identified by their physical constants (F, (0 O, UV, IR, mass spectrum) with reference samples such as: apo-vincamine (VII) (120 g), vincamine (V) (330 g) and epi-16-vincamine (VI) (150 g). The same reaction between (IV) and the triphenylphosphine conducted in acetic acid in the same conditions but at room temperature for 12 hours yielded 85% of a crude mixture containing only traces of apo-vincamine and consisting largely of vincamine (V) (3 parts) and epi-16-vincamine ( VI) (1 part).

EKSEMPEL 2EXAMPLE 2

Fremstlling af (-)-1,2-dehydro-16-carbomethoxy-16-hydroxv-aspido-spermidin-N-oxid (IV)-ud fra (II)Preparation of (-) - 1,2-dehydro-16-carbomethoxy-16-hydroxy-aspido-spermidine N-oxide (IV) ex from (II)

En opløsning af 1,360 kg (-)-vincadifformin (II) og 1,600 kg paranitroperbenzosyre i 200 liter tør benzen henstår 5 dage i nitrogenatmosfære og i fravær af lys. På dette trin viser en kontrol ved hjælp af chromatografi på tyndtlagsplade forsvinden af udgangsmaterialet (II) og mellemproduktet (III) og disses erstatning med (IV). Reaktionsopløsningen, der behandles som i de foregående eksempler, fører ved isolering til 1,250 kg derivat (IV). Udbytte 84%.A solution of 1,360 kg (-) - vincadifformin (II) and 1,600 kg of paranitroperbenzoic acid in 200 liters of dry benzene is left for 5 days in a nitrogen atmosphere and in the absence of light. In this step, a control by thin-layer chromatography shows the disappearance of the starting material (II) and the intermediate (III) and their replacement with (IV). The reaction solution, treated as in the previous examples, leads to isolation to 1,250 kg of derivative (IV). Yield 84%.

Den samme reaktion gennemført i tør methylenchlorid i stedet for benzen fører til det samme derivat (IV) med et udbytte pi 80%.The same reaction carried out in dry methylene chloride instead of benzene leads to the same derivative (IV) with a yield of 80%.

Claims (2)

143562143562 1. Fremgangsmåde til fremstilling af (-)-vincamin med formlen: OgCCl (V) h°— / I / I * H_ COOC/ L 3 kendetegnet ved, et (-)-tebersonln med formlen: Ol- i a_V>r (i) H COOCH3 i et første trin hydrogeneres katalytisk til næsten kvantitativ opnåelse af (-)-vincadifformin med formlen: \ 1·^ il-VV .(II) "Ί H COOCH3 ! og at det således opnåede (-)-vincadifformin (a) enten behandles med en ækvimolær mængde af et peroxid for i et andet trin at omdanne denne forbindelse til (-)-vIncadifformin-N-oxid med formlen: 143562 o ^Ί" ^ (III) i c°och3 J og at det således opnåede (-)-vincadifformin-N-oxid i et tredie trin påny behandles med en ækvimolær mængde af et peroxid til opnåelse af (-)-1,2-dehydro-16-carbomethoxy-16-hydroxy-aspidospermidin-N-oxid med formlen: 0 (IV) Γ“ ; cooch3 eller (b) behandles med to mol peroxid pr. mol (-)-vincadifformin i længere tid til direkte dannelse af (-)-1,2-dehydro-16-carbomethoxy--16-hydroxy-aspidospermidin-N-oxid med formlen IV, og at forbindelsen med formlen IV behandles med en ækvimolær mængde af triphenylphos-phin eller med et andet reduktionsmiddel for N-oxidgruppen i surt miljø til omlejring af produktet til en blanding af (-)-vincamin, 16-epi--vincamin og apo-vincamin, hvorefter (-)-vincamin udvindes.A process for the preparation of (-) - vincamine of the formula: OgCCl (V) h ° - / I / I * H_COOC / L 3 characterized by, a (-) - tea person of the formula: Ol- i a_V> r ( (i) In a first step, H COOCH3 is catalytically hydrogenated to give almost quantitative yield of (-) - vincadifformin of the formula: - (II) "Ί H COOCH3! a) is either treated with an equimolar amount of a peroxide to convert, in a second step, this compound to (-) - vincadifformin-N-oxide of the formula: (III) obtained (-) - vincadifformin N-oxide in a third step is again treated with an equimolar amount of a peroxide to give (-) - 1,2-dehydro-16-carbomethoxy-16-hydroxy-aspidospermidine N-oxide with the formula: 0 (IV) ΓΓ; cooch3 or (b) is treated with two moles of peroxide per ml. molar (-) - vincadifformin for an extended period to directly form (-) - 1,2-dehydro-16-carbomethoxy - 16-hydroxy-aspidospermidine N-oxide of Formula IV and treating the compound of Formula IV with a equimolar amount of triphenylphosphine or with another reducing agent for the N-oxide group in acidic environment to rearrange the product into a mixture of (-) - vincamine, 16-epi - vincamine and apo-vincamine, after which (-) - vincamine is recovered . 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at forbindelsen med formlen IV og en ækvimolær mængde triphe-nylphosphin opløses i en væskeformig organisk syre med lav molekylvægt og fortrinsvis i eddikesyre, at opløsningen efter to timers kogning i nitrogenatmosfære afkøles, fortyndes med en lige si stor mængde vand og vaskes med en dobbelt så stor mængde benzen eller ether for at fjerne det dannede triphenylphosphinoxid, at den flygtige organiske fase fjernes ved dekantering, at den sure vandige fase derefter gøres alkalisk tif en pH-værdi på 10 og ekstraheres med etProcess according to claim 1, characterized in that the compound of formula IV and an equimolar amount of triphenylphosphine are dissolved in a low molecular weight liquid organic acid and preferably in acetic acid, which is cooled after two hours of boiling in a nitrogen atmosphere. in a large amount of water and washed with twice the amount of benzene or ether to remove the resulting triphenylphosphine oxide that the volatile organic phase is removed by decantation, then the acidic aqueous phase is then made alkaline to a pH of 10 and extracted with a
DK16772A 1971-01-15 1972-01-13 PROCEDURE FOR THE PREPARATION OF (-) - VINCAMIN DK143562C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
BE761628 1971-01-15
BE761628A BE761628A (en) 1971-01-15 1971-01-15 PROCESS FOR PREPARING NATURAL VINCAMINE FROM LATABERSONIN AND NEW INDOLIC DERIVATIVES.
BE763730A BE763730R (en) 1971-01-15 1971-03-03 PROCESS FOR PREPARING NATURAL VINCAMINE FROM LATABERSONIN AND INDOLIC DERIVATIVES
BE763730 1971-03-03

Publications (2)

Publication Number Publication Date
DK143562B true DK143562B (en) 1981-09-07
DK143562C DK143562C (en) 1982-02-01

Family

ID=25656882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16772A DK143562C (en) 1971-01-15 1972-01-13 PROCEDURE FOR THE PREPARATION OF (-) - VINCAMIN

Country Status (4)

Country Link
JP (1) JPS5133120B1 (en)
DK (1) DK143562C (en)
ES (2) ES398499A1 (en)
IT (1) IT1043893B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6062078U (en) * 1983-10-03 1985-04-30 本州製紙株式会社 pest repellent container

Also Published As

Publication number Publication date
IT1043893B (en) 1980-02-29
ES398499A1 (en) 1975-09-16
DK143562C (en) 1982-02-01
JPS5133120B1 (en) 1976-09-17
ES425906A1 (en) 1976-09-01

Similar Documents

Publication Publication Date Title
Jossang et al. Horsfiline, an oxindole alkaloid from Horsfieldia superba
Roberts et al. Macrocyclic Diterpenes. α-and β-4, 8, 13-Duvatriene-1, 3-diols from Tobacco1
Sakai et al. The structure and stereochemistry of four new sesquiterpenes isolated from the wood oil of “Kaya”(Torreya nucifera)
Uskokovic et al. Asymmetric synthesis of allo-heteroyohimbine alkaloids
Sonnet et al. Synthesis of insect trail pheromones: The isomeric 3‐butyl‐5‐methyloctahydroindolizines
Culvenor The Alkaloids of Heliotropium europaeum L.. II. Isolation and structures of the third major alkaloid and two monor alkaloids, and isolation of the principal n-Oxides
Frankenburg et al. The chemistry of tobacco fermentation. I. Conversion of the alkaloids. D. Identification of cotinine in fermented leaves
Yates et al. Some Cyclopentenones and Supposed Cyclopentenones
US3892755A (en) Process of preparation of vincamine from tabersonine
DK143562B (en) PROCEDURE FOR THE PREPARATION OF (-) - VINCAMIN
Badger et al. Isolation of tetrahydroharman from Petalostyles labicheoides
Zimmerman et al. Cyclopropene photochemistry. Part 4. Mechanistic and exploratory organic photochemistry. Part 134
Demole et al. A Chemical Study of Burley Tobacco Flavour (Nicotiana tabacuml.) V. Identification and Synthesis of the Novel Terpenoid Alkaloids 1, 3, 6, 6‐Tetramethyl‐5, 6, 7, 8‐tetrahydro‐isoquinolin‐8‐one and 3, 6, 6‐Trimethyl‐5, 6‐dihydro‐7H‐2‐pyrindin‐7‐one
US3799933A (en) Method of preparing new indolic derivatives usable for synthesizing dextro-rotary vincamine
Kuehne et al. Thiyl radical-and mercuric ion-induced cyclizations of dimethyl dipropargylmalonate and dimethyl propargyl-3-thiylallylmalonates
SU657751A3 (en) Method of obtaining vincamine and/or epi-16-vincamine
Bencze et al. Photochemical Preparation, Rearrangement, and Dehydration of Symmetrical Methyl and Phenyl Pyridyl Glycols
Bradsher et al. Aromatic Cyclodehydration. 1 XLIV. The Benz [b] Acridizinium System2
US3118947A (en) Epoxide conversion process
Cram Mold metabolites. V. The stereochemistry and ultraviolet absorption spectrum of citrinin
Kitagawa et al. 758. Stereochemistry of lycorenine, homolycorine, pluviine, and their hydrogenation products
US3894028A (en) Process for the preparation of optical antipode of vincamine and new indole derivatives
Cacchi et al. New approach to. alpha.-keto esters
Starkowsky et al. Ammajin, a new constituent of Ammi majus (L.)
Hendrickson et al. 321. Sesquiterpenes. Part II. The double-bond derivatives of santonin

Legal Events

Date Code Title Description
PUP Patent expired